Lexicon Pharmaceuticals
LXRX
#7142
Rank
$0.50 B
Marketcap
$1.40
Share price
-1.41%
Change (1 day)
97.18%
Change (1 year)

Market capitalization of Lexicon Pharmaceuticals (LXRX)

Market cap: $0.50 Billion USD

As of December 2025 Lexicon Pharmaceuticals has a market cap of $0.50 Billion USD. This makes Lexicon Pharmaceuticals the world's 7142th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lexicon Pharmaceuticals from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025$0.50 B81.97%
2024$0.27 B-25.39%
2023$0.37 B3.96%
2022$0.36 B-38.55%
2021$0.58 B21.23%
2020$0.48 B9.72%
2019$0.44 B-37.3%
2018$0.70 B-32.58%
2017$1.04 B-27.5%
2016$1.43 B4.32%
2015$1.37 B109.26%
2014$0.65 B-28.66%
2013$0.92 B-18.41%
2012$1.13 B159.95%
2011$0.43 B-10.35%
2010$0.48 B62.66%
2009$0.29 B55.97%
2008$0.19 B-53.79%
2007$0.41 B47.57%
2006$0.28 B19.2%
2005$0.23 B-52.15%
2004$0.49 B33.06%
2003$0.37 B49.4%
2002$0.24 B-58.74%
2001$0.60 B-25.19%
2000$0.80 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Lexicon Pharmaceuticals was reported to be:

$0.50 Billion USD
by Nasdaq info icon info icon
$0.50 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eterna Therapeutics
ERNA
$10.36 M-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$76.13 B 14,865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$3.50 B 589.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$10.25 B 1,916.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$215.19 B 42,197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.88 B 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$19.82 B 3,795.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$3.63 B 615.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.75 B 48.13%๐Ÿ‡บ๐Ÿ‡ธ USA